Table 1.
Baseline characteristics of HCV and HBV cohorts.
| Characteristic | HCV (n = 1803) | HBV (n = 1652) | p value |
|---|---|---|---|
| Sex — Male | 864 (47.92) | 1013 (61.32) | <0.001 |
| Age — years | 61.61 ± 14.15 | 50.22 ± 14.92 | <0.001 |
| Platelet (x109/L) | 176.83 ± 72.97 | 194.79 ± 70.39 | <0.001 |
| Platelet level | |||
| 1 (≥150 × 109/L) | 1145 (63.51) | 1270 (76.88) | <0.001 |
| 2 (≥100–149 × 109/L) | 444 (24.63) | 277 (16.77) | |
| 3 (≥50–99 × 109/L) | 182 (10.09) | 79 (4.78) | |
| 4 (≥30–49 × 109/L) | 22 (1.22) | 19 (1.15) | |
| 5 (<30 × 109/L) | 10 (0.55) | 7 (0.42) | |
| WBC (x106/L) | 7.04 ± 3.22 | 7.28 ± 2.98 | 0.021 |
| Hemoglobin - g/dL | 13.21 ± 1.95 | 13.76 ± 2.01 | <0.001 |
| AST — U/L | 92.00 ± 209.98 | 95.89 ± 299.87 | 0.668 |
| ALT — U/L | 122.17 ± 247.51 | 110.69 ± 307.71 | 0.232 |
| ALP —U/L | 88.75 ± 49.14 | 79.92 ± 39.43 | <0.001 |
| Albumin — g/dL | 3.86 ± 0.71 | 3.86 ± 0.79 | 0.920 |
| Total bilirubin —mg/dL | 1.36 ± 2.42 | 1.37 ± 2.14 | 0.899 |
| PT prolong—second | 0.73 ± 3.11 | 0.93 ± 4.08 | 0.177 |
| Spleen index | 15.79 ± 7.73 | 13.91 ± 6.73 | <0.001 |
| Splenomegaly-Positive | 357 (23.47) | 182 (12.88) | <0.001 |
| Cirrhosis -Positive | 173 (10.80) | 125 (8.49) | 0.031 |
| Child-Pugh classification (cirrhosis positive only)— n (%) | |||
| A | 72 (59.02) | 29 (34.94) | <0.001 |
| B | 42 (34.43) | 38 (45.78) | |
| C | 8 (6.56) | 16 (19.28) | |
Abbreviations: HCV: hepatitis C virus; HBV: hepatitis B virus; WBC: white blood cell; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; PT: prothrombin time; SD: standard deviation.
The descriptive statistics were presented as mean ± sd or frequency (%).